Analyze Diet
Applied microbiology and biotechnology2017; 102(1); 413-423; doi: 10.1007/s00253-017-8610-0

Optimization and application of a DNA-launched infectious clone of equine arteritis virus.

Abstract: Reverse genetics is one of the most powerful tools in modern virology. Equine arteritis virus (EAV) is the prototype member of the Equartevirus. In this study, a new reverse genetics system for the recovery of equine arteritis virus from a cDNA plasmid, which contains viral cDNA sequence flanked by hammerhead ribozyme (HamRz) and hepatitis delta virus ribozyme (HdvRz) sequences in both terminals of the viral genome, was developed by optimization of the promoter and terminator regions. Cellular RNA polymerase II drove the transcription of the viral genome. The results showed that the rescued virus (ic-EAV) shared similar morphological and growth characteristics with the wild-type (WT) virus, and could be distinguished from the WT virus via an engineered BspEI restriction site in the nsp3 gene. By using the reverse genetics method established in this study, a G-to-C silent mutation at site 12642 resulted in a significant change in the plaque size of the rescued virus. Moreover, an eGFP-labeled EAV was constructed by introducing the eGFP gene into the infectious clone of EAV, which facilitated the observation of the infection of EAV in target cells. Hence, the newly reverse genetics method of EAV established in this study can be easily manipulated and would be helpful for studying the pathogenic mechanism of EAV.
Publication Date: 2017-11-13 PubMed ID: 29134331DOI: 10.1007/s00253-017-8610-0Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores the development and application of a new system to control and manipulate Equine Arteritis Virus (EAV), a prototype member of the Equartevirus. Using a modified cDNA plasmid and reverse genetic techniques, a genetically engineered version of EAV was created which could be potentially useful for scientific investigation into the virus’s pathogenic mechanisms.

Development of a New Reverse Genetics System

  • The researchers created a cDNA plasmid, a piece of DNA that can replicate in the host cell, by flanking the EAV’s viral cDNA sequence with hammerhead ribozyme (HamRz) and hepatitis delta virus ribozyme (HdvRz) sequences. These special sequences were placed at both ends of the viral genome.
  • They then optimized the promoter and terminator regions, which control the start and end of transcription, to enable the replication of the viral genome by the cell’s RNA polymerase II enzyme.

Characteristics of the Rescued Virus

  • The rescued virus, ic-EAV, exhibited similar growth characteristics and morphology as the wild-type (WT) virus.
  • Additionally, a unique BspEI restriction site was engineered into the nsp3 gene of the ic-EAV, which allowed differentiation of the rescued virus from the wild type.

Mutation and its Impact

  • Through the established method, a G-to-C silent mutation was introduced at site 12642, which triggered a significant change in the plaque size of the rescued virus. Although the mutation does not alter the protein produced, it seems to considerably impact the virus’s growth behavior.

Creation of a Labeled EAV

  • An eGFP-labeled EAV was built by introducing the gene for Green Fluorescent Protein (eGFP) into the EAV’s infectious clone.
  • This genetic modification allowed the observation of EAV’s infection process in the target cells, highlighting the potential of this reverse genetics method in facilitating further research into the virus’s pathogenesis.

In conclusion, the reverse genetics method presented in this study provides a manipulable tool to enable detailed investigations into the mechanics of EAV.

Cite This Article

APA
Qi T, Wang X. (2017). Optimization and application of a DNA-launched infectious clone of equine arteritis virus. Appl Microbiol Biotechnol, 102(1), 413-423. https://doi.org/10.1007/s00253-017-8610-0

Publication

ISSN: 1432-0614
NlmUniqueID: 8406612
Country: Germany
Language: English
Volume: 102
Issue: 1
Pages: 413-423

Researcher Affiliations

Qi, Ting
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 678 Haping Road, Harbin, 150069, People's Republic of China.
Wang, Xiaojun
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 678 Haping Road, Harbin, 150069, People's Republic of China. xjw@hvri.ac.cn.

MeSH Terms

  • Animals
  • Cell Line
  • Cells, Cultured
  • Cloning, Molecular / methods
  • DNA, Complementary / genetics
  • DNA, Viral / genetics
  • Equartevirus / genetics
  • Equartevirus / growth & development
  • Equartevirus / isolation & purification
  • Genetic Vectors
  • Genome, Viral
  • Horses
  • Plasmids / genetics
  • RNA Polymerase II / genetics
  • RNA, Viral / genetics
  • Reverse Genetics / methods
  • Virion / genetics

Grant Funding

  • 31402203 / National Natural Science Foundation of China
  • C2017080 / Natural Science Foundation of Heilongjiang Province